Back to search

Article

Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer

2020-04-16

Abstract excerpt

Early-onset sporadic rectal cancer (EOSRC) is a unique and predominant colorectal cancer (CRC) subtype in India. In order to understand the tumorigenic process in EOSRC, we performed whole exome sequencing of 47 microsatellite stable EOSRC samples. Signature 1 was the predominant mutational signature in EOSRC, as previously shown in other CRC exome studies. More importantly, we identified TP53, KRAS, APC, PIK3R1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
29ef1391-c4d6-5bbb-84bc-4c4c47b03e86
DOI
10.1101/2020.04.15.040741
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancerDOI 10.1101/2020.04.15.040741
Select a neighboring publication to make it the new centre.